November 13th, 2009

Podcast 65: A conversation about the utility of renovascular angioplasty in the face of atherosclerosis

(1 votes, average: 1.00 out of 5)

Investigators have suspected that there isn’t much advantage to renovascular angioplasty and stenting in atherosclerosis, but their studies haven’t had the statistical power to prove that point. A new bit of research in this week’s New England Journal of Medicine may have hit the mark. We’ve got an interview with two of the principals of the ASTRAL study (that’s their acronym for Angioplasty and Stenting for Renal Artery Lesions). Dr. Philip Kalra, the nephrology lead, and Dr. Jonathan Moss, the radiology lead, kindly agreed to the conversation, which I think you’ll find of interest.

Reach us with your comments and suggestions at jelia@jwatch.org, or call 1-617-440-4374.

This edition’s links:

Interview link–

News links–

Comments are closed.

Clinical Conversations

About the Podcast

To subscribe: Subscribe on iTunes

To have your comment included in a future podcast, call 617-440-4374. Please leave your name, number, and the podcast ID number.